Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review
- PMID: 37855757
- DOI: 10.1016/j.jacc.2023.08.012
Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review
Abstract
As a result of increasing adoption of imaging screening, the number of adult patients with a diagnosis of anomalous aortic origin of the coronary arteries (AAOCA) has grown in recent years. Existing guidelines provide a framework for management and treatment, but patients with AAOCA present with a wide range of anomalies and symptoms that make general recommendations of limited applicability. In particular, a large spectrum of interventions can be used for treatment, and there is no consensus on the optimal approach to be used. In this paper, a multidisciplinary group of clinical and interventional cardiologists and cardiac surgeons performed a systematic review and critical evaluation of the available evidence on the interventional treatment of AAOCA in adult patients. Using a structured Delphi process, the group agreed on expert recommendations that are intended to complement existing clinical practice guidelines.
Keywords: AAOCA; anomalous origin coronary arteries; coronary anomaly; treatment.
Copyright © 2023 American College of Cardiology and The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures Dr Di Franco has served as a consultant for Novo Nordisk and Servier; and has served as an advisory board member for Scharper. Dr Gräni has received funding from the Swiss National Science Foundation, InnoSuisse, the GAMBIT foundation, and the CAIM foundation, outside of the submitted work. Dr Weinsaft has received speaker fees from GE Healthcare; and has served as a consultant for Bitterroot Bio. Dr Zimpfer has served as an advisor and advisory board member for Medtronic, Abbott, Berlin Heart, Abiomed, Fineheart, and Corewave; has served on the Speakers Bureau for Medtronic, Abbott, Berlin Heart, Abiomed, Corzym, and Edwards Lifesciences; and has received research grants and travel support from Medtronic, Abbott, Berlin Heart, Abiomed, Corzym, and Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials